The identification of metabolomic biomarkers typically involves several steps. First, biological samples are collected from study participants. These samples are then analyzed using advanced technologies such as mass spectrometry or nuclear magnetic resonance spectroscopy. The resulting data is processed and analyzed to identify specific metabolites that are associated with the disease or condition of interest. Statistical and bioinformatics tools are used to validate these findings and determine their significance.
